Добавить в папку Экспорт Добавить в избранное Добавить в архив

Холдинг
ID ...... Создание производства противоязвенных препаратов

А
  • Дата добавления

    29.10.2019
  • Последнее обновление

    13.11.2020
  • Краткое описание

    В Уральском ФО наладят выпуск противоязвенного препарата из фармсубстанций собственного производства. Общая стоимость проекта составляет 215 млн рублей.
  • Полное описание

    ················ ···· ···· ···· ········ ·············· ········ ········ ·········· ······ ······ ········ ················ ········ ······ ······ ················ ················ ············ ·············· ···· ······ ·········· ········ ······ ················ ·············· ············ ······ ·········· ···· ···· ·············· ········ ········ ···· ················ ·········· ········ ········ ······ ······ ······ ················ ············ ···· ···· ·············· ············ ········ ···· ················ ······ ········ ················ ······ ········ ·············· ············ ············
  • Результаты интервью

    ···· ·················· ···· ····.····.········ ············ ················ ························ ······························ ···················· ·················· ···· ············ ·············· ·············· ········ ···· ········

    ···· ·················· ···· ····.····.········ ············ ···· ············ ························ ············ ·········· ·············· ···· ·········· ··········

    ···· ·················· ···· ····.····.········ ········ ·················· ···················· ·· ··.····.········ ······················ ············ ···················· ························ ············

  • Объем инвестиций

    ············ ············
  • Холдинг инвестора

Прогноз расхода материала

Материал
Стадия проекта

Инвестор

+ 7

Генеральный проектировщик

Генеральный подрядчик

Портал инвестиционных проектов России <http://investprojects.info/projects/newmy?project_id=26473>
Вся информация, размещенная на данном веб-сайте, предназначена только для персонального пользования и не подлежит дальнейшему воспроизведению и / или распространению в какой-либо форме, иначе как с письменного разрешения Инвестиционной группы "Профессиональные Комплексные Решения" (ПКР)
Показать